Details for Patent: 11,491,163
✉ Email this page to a colleague
Which drugs does patent 11,491,163 protect, and when does it expire?
Patent 11,491,163 protects TAZVERIK and is included in one NDA.
This patent has fifty-nine patent family members in twenty-four countries.
Drugs Protected by US Patent 11,491,163
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epizyme Inc | TAZVERIK | tazemetostat hydrobromide | TABLET;ORAL | 211723-001 | Jan 23, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF TREATING RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA POSITIVE FOR AN ENHANCER OF ZESTE HOMOLOG 2 (EZH2) MUTATION | ⤷ Try a Trial | ||||
Epizyme Inc | TAZVERIK | tazemetostat hydrobromide | TABLET;ORAL | 211723-001 | Jan 23, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF TREATING RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA | ⤷ Try a Trial | ||||
Epizyme Inc | TAZVERIK | tazemetostat hydrobromide | TABLET;ORAL | 211723-001 | Jan 23, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF TREATING EPITHELIOID SARCOMA | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,491,163
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2013245878 | ⤷ Try a Trial | |||
Australia | 2018200168 | ⤷ Try a Trial | |||
Brazil | 112014025508 | ⤷ Try a Trial | |||
Canada | 2870005 | ⤷ Try a Trial | |||
China | 104603130 | ⤷ Try a Trial | |||
China | 108358899 | ⤷ Try a Trial | |||
Cyprus | 1119383 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |